Biotech

All Articles

Novo inks $600M NanoVation deal to study genetic medications ex-liver

.Novo Nordisk is proceeding its own press right into genetic medications, accepting compensate NanoV...

Innovent hyperlinks cytokine to colon cancer cells reactions

.Innovent Biologics has made the instance that its own checkpoint inhibitor-cytokine blend healthy p...

Merck, Daiichi ADC reaches target in phase 3 bronchi cancer cells study

.A period 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) ...

Rakovina deepens artificial intelligence concentrate along with collab to choose cancer cells aim ats

.5 months after Rakovina Therapeutics turned toward expert system, the cancer-focused biotech has si...

Ascendis' dwarfism drug favorites in period 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a possible danger to BioMarin's Voxzogo, disclosing period ...

Despite ph. 3 skip, Alkeus finds road in advance for eye health condition resource

.Though Alkeus Pharmaceuticals' dental eye health condition property stopped working to significantl...

Kairos goes public with $6M IPO to money tests of cancer cells medicine

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was actually quick and easy to miss ...

Vaccine as well as Keytruda combo reliable in squamous tissue cancer

.Immune gate preventions are the superheroes of cancer cells treatment. Medications like Bristol Mye...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of considerable management hirings, shooting...

Regeneron's Opdualag rival reveals 57% action fee

.Regeneron is actually back with lasting consequence for its LAG-3 inhibitor as well as PD-1 prevent...